US licensing deal for AFT Pharma

Apr 28, 2021 | Uncategorized

28.4.21 AFT Pharmaceuticals were again an out-performer on the NZX market , rising 50c to $4.50 on news it has achieved the first out licensing of the Maxigesic family of medicines into the US market. AFT Pharmaceuticals has signed an exclusive License and Distribution Agreement with Hikma Pharmaceuticals USA for the commercialisation of its Maxigesic […]

 


 

You need an active membership to keep reading

either log in via the form below or click here to subscribe

If you have recently subscribed and selected to pay by bank transfer our admin team will activate your membership once payment has cleared

Your Advertisement Here

Contact us now to discuss advertising options

Your Advertisement Here

Contact us now to discuss advertising options